Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Yellow iron oxide has a long story. Long before lab coats and strict documentation, workers used iron-rich clays in medicine and paint. As pharmaceutical production tightened standards, refiners learned—through plenty of trial and error—how purification changed medicinal quality. Europe led the charge. Compounded pharmacies during the industrial revolution depended on stable pigments, so iron oxides became tightly regulated. British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) later established boundaries for impurities and particle size, building on millennia of trial, mistake, and careful observation.
Most people outside pharmaceutical or chemical manufacturing see yellow iron oxide only as a pigment. But this substance, often labeled ferric oxide hydrate or hydrated iron(III) oxide, shows up almost everywhere—on pill coatings, tablets, sunscreens, and even in diagnostic procedures. The BP, EP, and USP standards keep it chemically consistent and free from hazardous levels of impurities like arsenic, lead, or mercury. Manufacturers carefully match each batch to the guidelines, so a doctor or pharmacist somewhere can trust they will get a reproducible, safe ingredient.
Yellow iron oxide comes out as a fine, yellow powder with subtle orange or brown undertones. It rarely clumps under dry storage because moisture content stays low—usually under two percent by weight. Solubility reports show it won’t dissolve in water or alcohol, which stops it from leaching into the surrounding medium in tablet formulations or topical creams. Chemically, it takes the form FeO(OH)·nH2O, where “n” signals some wiggle room on the water molecules per iron atom. Melting doesn’t happen since it breaks down before that temp; roasting it above 200°C often flips it toward red iron oxide (hematite) as dehydration and oxidation take over. The yellow powder also absorbs visible and UV light, crucial for its protective action in sunscreen and as opacity control in pharmaceuticals.
Most pharmacopeia documents want strict answers to particle size, heavy metal contamination, color intensity, and pH in dispersion. In my time around formulation chemists, I’ve watched entire batches of iron oxide get trashed for exceeding the tiniest lead threshold—no one wants heavy metals anywhere near medication or skin. Labels list the substance as “Yellow Iron Oxide,” followed by a code (usually CI 77492 or E172 in Europe) and a specification number documenting that lot’s lab tests. Traceability follows every kilo from the origin of iron ore to the manufacturer that puts it on a shelf or inside a tablet.
Modern production borrows from Victorian-era techniques but trades a cauldron for a reactor vessel. Producers react ferrous sulfate with sodium hydroxide, then blow air through the mixture. The Fe2+ converts to Fe3+, and yellow hydrated iron oxide precipitates out. Careful washing, filtration, and drying hold down the metallic impurities and size variance. Stepwise heating fine-tunes the crystal structure, and because the end-user constantly demands higher and higher purity, each stage lines up for routine testing. Once milled to a fine grain, the product packs into airtight bags to prevent moisture re-adsorption and cross-contamination.
Iron oxides never quite sit still, even after collection. Roasting yellow iron oxide moves the color toward red, used for other pigments or ceramics. Too much acid around? The yellow compound shifts to soluble ferric salts. Put yellow iron oxide in an alkaline environment; you’ll see partial dissolution, sometimes followed by precipitation as another hydrate. These behaviors inform how formulators mix it with excipients or binders—some can’t take the risk of interaction, while others harness its resistance to chemical attack for stable, long-lived medicines.
Yellow iron oxide wears many hats. Labels at the raw chemical supplier might call it “ferric oxide-hydrate,” “hydrated iron(III) oxide,” or simply “yellow oxide of iron.” Coding systems like Colour Index (CI 77492), European E-number (E172), and even old-school ferric hydroxide yellow can pop up. The core chemical stays the same, but branding and regulatory language shift depending on the product’s end user—tablets, skin creams, paints, or lab reagents.
Every laboratory worker I know who’s handled yellow iron oxide ends up dusted yellow at some point, usually by accident. Even though official studies classify it as non-toxic in the amounts used for pharmaceuticals, labs post dust-control instructions on every door and supply staff with fitted masks. The most recent toxicology reviews set the threshold limit value (TLV) for iron oxide dust at around 5 mg/m³ for an eight-hour workday. That’s conservative, designed to protect technicians from developing any respiratory irritation, not because iron oxide itself causes serious disease. Storage focuses on keeping the powder dry, away from strong acids, and locked inside well-labeled containers—especially important in facilities handling dozens of fine powders day in, day out.
Yellow iron oxide’s reach stretches further than most realize. Pharmacists rely on it to color-code tablets for quick identification and patient compliance. In sunscreens and topical medicines, it shields against ultraviolet light, boosting safety. Medical device companies sometimes use it as a contrast medium or inert filler. Researchers mix it into in vitro diagnostic kits as a color marker for reactions. Nobody working with oral or topical pharmaceuticals avoids iron oxide outright—in some factories, the color yellow means an easy visual check for contamination, counterfeit tablets, or manufacturing slip-ups.
Research rarely stands still long in this corner of pharmaceutical chemistry. Many labs dig into how particle size changes drug release rates or interacts with new coating polymers. As high-potency and biologic medicines move forward, regulators push for data on whether very fine iron oxide particles migrate across intestinal barriers or the skin. Analytical chemists are also racing to detect ultratrace contaminants, as mass spec equipment grows more sensitive each year. Some of the newest projects even explore using nano-structured iron oxide for slow-release drugs or targeted imaging.
Most toxicity studies pin down yellow iron oxide as safe so long as it stays under controlled exposure levels. Rats and other lab animals ingesting normal pharmaceutical doses show no evidence of cancer or long-term tissue damage. Still, peer-reviewed journals warn against inhaling lots of dust, citing rare cases of siderosis (iron overload in the lungs) among workers at iron oxide mines or older pigment grinding shops. Allergic reactions almost never pop up, but topical use sometimes causes irritation for people with sensitive skin. The industry keeps a close watch on new findings, and regulatory agencies demand regular, transparent reassessment to catch any overlooked risks.
Pharmaceutical-grade yellow iron oxide’s future looks solid but not unchanging. Quality control now leans into digital batch tracking and more advanced inline testing, where tiny spectrometers catch off-specification batches before packaging. Growing debate surrounds nanostructured oxides or “ultrafine” pigments—how much smaller can the particles get before new health questions crop up? Demand edges upward as rapid diagnostics, cell labeling, and advanced coatings grow. Some researchers push for biodegradable or bioresorbable modifications, aiming to adapt iron oxide’s chemical backbone for greener processes. With the shift in regulatory focus from batch data to total supply chain transparency, the bar rises for everyone—from the miner to the tablet press operator.
Yellow iron oxide appears simple—a yellow pigment, nothing more. In the hands of pharmaceutical manufacturers, it takes on a bigger role. Picture the shelves at your neighborhood drugstore. Every tablet, ointment, and supplement comes with its own color. This isn’t just for making the medicine look appealing or to help patients tell tablets apart. Sometimes, color protects medicines from light or camouflages an unpleasant look that could lead to poor patient compliance.
Yellow iron oxide, in the grades known as BP, EP, and USP, stands out because it’s been tested for purity and safety. These standards help make sure what ends up in medicines doesn’t carry unwanted contaminants like heavy metals. Not every pigment qualifies for that kind of approval. The pharmaceutical world demands these assurances since the medicines go straight into the hands—and bodies—of patients.
Think of a classic painkiller tablet. The color serves a functional purpose. Yellow iron oxide acts as a pigment. Companies prefer it because synthetic dyes often cause allergic reactions and can break down over time. Mineral pigments like iron oxides offer better stability. They won't fade quickly or interact with other ingredients in awkward ways.
I’ve worked in GMP-compliant facilities where the tiniest trace of an unwanted element meant the whole batch got scrapped. Our team needed pigments that didn’t just pass one country’s checks but also met the needs of regulators worldwide. Yellow iron oxide met that challenge. It didn’t add flavor, so patients didn’t complain. Its chemical stability protected the integrity of the pill, which matters when drugs travel through high temperatures or get stored for months in hospital stocks.
People rarely think about color as a matter of safety, but medicine manufacturers do. BP, EP, and USP grades of yellow iron oxide pass through a net of regulations before reaching the production line. If a pigment isn’t this pure, toxic metals can sneak in. These standards keep those risks away. The 2019 recall of certain antacids in South Asia over contaminated colorants made it clear that a missed contaminant isn’t minor—it leads to trust lost, in both manufacturers and regulators.
In pharmaceutical coloring, reproducibility is king. Patients expect the same yellow shade every time, and pharmacists rely on this familiar appearance to avoid the mix-ups that can cost lives. Yellow iron oxide in these official grades guarantees the same recipe on every continent, every time.
Finding dependable sources produces its own headaches. Few suppliers carry certified stocks, which sometimes pushes up costs. If a raw material changes—say, a supplier switches mines or purification processes—the color can shift, even if it barely shows up in the lab. This creates a logistical headache. To cope, some companies set up their own in-house quality control labs or partner with analytical chemists. Frequent batch testing, strict audits, and dedicated traceability processes can help.
Sustainability also comes up more now. Manufacturers weigh environmental impact alongside purity. Changes in mining practices, pressure to use recycled materials, and new regulations will push the pigment industry in new directions.
On the surface, a yellow pill only looks different; inside, it represents years of safety testing and constant vigilance. The medical world keeps demanding colorants that deliver on purity, batch after batch, because patients’ trust runs deeper than a shade on a capsule.
Yellow iron oxide shows up in tablets, capsules, and ointments across global medicine cabinets. People often ask if this pigment, stamped with BP, EP, and USP badges, stands up to the safety standards we expect in healthcare. It's a fair question, given how ingredients can sneak into the body and linger unnoticed.
Pharmaceutical companies turn to yellow iron oxide because it's more than a splash of color. The deep yellow helps doctors, pharmacists, and patients tell one tablet from another. Mistaking blood-pressure medicine for painkillers or antibiotics could go badly wrong. I’ve seen hospital wards where color coding meant the difference between safe and dangerous medication routines.
Drug manufacturers can't just dump a pretty powder into pills. Yellow iron oxide that wears the BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) labels has met tough pharmaceutical purity tests. These standards rule out heavy metals, microbial contamination, and synthetic dyes not fit for human use. Without those badges, it gets hard to trust what's inside.
I’ve read through the official guidelines from these pharmacopeias, and they set tight limits on possible contaminants—a real lifesaver, since impurities like lead and arsenic pack serious health risks even in trace amounts. Regulators ask for defined particle size, chemical composition, and clear absence of leftover solvents or unknown substances.
Direct experience matters. Having seen yellow iron oxide used in batch after batch of commercial drugs, I haven't seen reports of allergic reactions or long-term buildup causing harm at pharmaceutical grade levels. Most side effects that get reported in the context of colored tablets stem from excipients like lactose or gluten, not the pigment.
Large regulatory bodies like the FDA confirm this trend. Clinical records and published case studies back up what’s seen on the ground: No meaningful link between properly purified yellow iron oxide and medical complications at regulated doses. It’s found in everyday products from headache tablets to eye drops.
People still harbor doubts, especially with rumors or clickbait headlines about artificial colors. Over my years in the field, clear labeling and honest communication from both the pharmaceutical industry and regulators have calmed most concerns. Patients deserve to know that pharma-grade yellow iron oxide is not just any pigment, but something that passed scrutiny in government labs.
Problems show up where manufacturers chase cost savings with pigments that fail to meet pharma specs. This shortcut culture risks letting through extra leftovers, toxic metals, or unpredictable interactions. The smartest fix is sticking to certified suppliers and demanding proof of origin, safety documentation, and regular audits. Several recalls in the past owe their headlines to companies skipping these steps, not to the pigments themselves.
In my own practice, sticking to pharma-grade yellow iron oxide in formulas has always delivered reliability. Patients rarely notice it, which might be the best proof of safety—a drug additive everyone can overlook, kept in check by decades of research and oversight. Relying on proven science and tight controls keeps unnecessary worry at bay.
Yellow iron oxide, known in labs by its chemical name ferric oxide-hydrate, turns up in a lot more than artists’ palettes. In the world of pharmaceuticals, where everything rides on safety and accuracy, this pigment carries its own set of strict requirements. Pharmacopoeia grades—BP (British Pharmacopoeia), EP (European Pharmacopoeia), USP (United States Pharmacopeia)—all ask for something a little different, yet share a core: purity wins every time.
The most important quality? Purity above 96%. Every reputable source will highlight this right at the top of a Certificate of Analysis. Yellow iron oxide must be free from other metal impurities—no detectable lead, arsenic, mercury, or cadmium sneaking through. Not long ago, a batch tainted with heavy metals slipped into a food additive shipment, leading to an immediate recall and big trust issues for the supplier. Monitoring these levels is more than checking a box—flawed quality control puts patients’ health and a manufacturer’s reputation on the line.
Manufacturers and regulators pay close attention to how this pigment spreads out, both in color and in texture. If you run your hand through a sample, you don’t want to see clumps or color streaks. Particle size tells you a lot about the manufacturing process: well-milled, sub-10 micron particles feel smooth, blend well, and stay put. Larger or uneven particles can mess with how a tablet looks or how a lotion feels on the skin.
And shade isn’t pure art in this case. A big skincare brand once launched a new sunscreen formula using a different batch of yellow iron oxide. Quality control missed that the color shifted from ochre to muddy brown. The product lost appeal, hit reviews, and the warehouse filled up with unsellable stock. Consistent, vibrant color matters for trust, taste, and aesthetics.
Lab techs always check pH, not just for standardization, but also for compatibility through the manufacturing process. Yellow iron oxide pharma grade needs a pH close to neutral—usually 4 to 7—so it doesn’t react with other ingredients. Skewed pH can throw off tablet stability or even impact skin-sensitive formulations.
I remember a tablet plant in Gujarat where a shipment came through with pH off by a single point. This tiny detail sent production back to raw material testing, and results looked fine on paper. The tablets failed stability trials down the line, costing weeks of lost batch time and warranty claims from overseas buyers. That’s a practical lesson in why these “small” metrics really shape the industrial outcome.
After burning off the sample, what’s left? High-quality yellow iron oxide should leave behind minimal residue, under 1%. This shows that the material doesn’t carry junk fillers or excess inorganic matter. Moisture also matters—levels need to stay below 1% too. Wet pigment can clump, spoil, or trigger microbial growth.
A friend in pharmaceutical QA once had his production batch fail because someone overlooked moisture readings—tablets warped, bottles fogged up, and wholesalers demanded returns. Consistent readings on these two specifications offer peace of mind and reduce risk.
Any supplier worth their salt will perform microbial testing, making sure no bacteria, yeast, or mold gets a free ride. Documentation, traceability, and transparent sourcing keep the entire supply chain honest. In the end, solid specifications for yellow iron oxide pharma grade give patients, manufacturers, and end users real reasons to relax. Regular audits, spot testing, and careful selection of raw materials offer real-world fixes—no shortcuts, no risky substitutes.
Stepping into a pharmaceutical or chemical storeroom, one thing becomes clear—you can’t afford to be sloppy with storage. I’ve watched many labs and production sites over the years, and every time someone overlooks proper handling, contamination and waste follow close behind. Yellow Iron Oxide often finds a spot on the ingredients list for tablets, capsules, and cosmetics. This yellow pigment does more than bring color; it sets a clear standard for purity and safety, thanks to its pharmaceutical grades like BP, EP, and USP.
I’ve seen humidity spoil batches before they even reach the blending stage. Yellow Iron Oxide clumps once it pulls moisture from the air, and the risk of microbial growth climbs. That’s why anyone working with this compound gets taught to use sealed, airtight containers. You’ll find that most reliable supply rooms store these pigments in thick, moisture-resistant bags or HDPE drums, topped with a tamper-evident cap. These containers don’t just keep liquid out—they block airborne dust and contaminants as well.
If you’ve ever stored ingredients in a sunlit space, you already know how sunlight and temperature swings can mess with powders. Sun-exposed rooms raise temperatures, sometimes bringing in humidity, too. Both ruin pigment performance. For Yellow Iron Oxide, cool, dry storage shields purity and keeps the pigment flowing. Temperatures under 25°C work well—room temperature storage prevents caking and color fading. Light-blocking bins or a shaded shelf prevent the pigment’s yellow tone from breaking down. I learned early on not to shortcut this, especially for pharma-grade goods—regulators check for even the hint of UV damage or color shift.
Storage feels like a simple job, but one misplaced drum can ruin a batch. Keeping Yellow Iron Oxide away from acids, alkalis, and volatile solvents shields it from harmful reactions. Some chemicals create unexpected fumes; others leach out moisture or release corrosive gases. I’ve seen isolated storage zones labeled for pigments, away from the hustle, the cleaning supplies, and anything reactive. Using physical barriers, like shelving or lockers dedicated to iron oxides, keeps cross-contamination headaches away.
Pharmaceutical rules call for clean working zones. You can’t sweep this under the rug—dust or spilled pigment means wasted product and cleaning nightmares. Every storage change, every transfer from drum to scoop, demands a designated clean area with easy-to-wipe surfaces. Scoop tools need regular sterilization, and operators benefit from gloves and dust masks—not just for their own safety, but to protect the product.
Every good storeroom uses a “first in, first out” system. Fresh pigment sits behind older drums. Labels carry arrival dates, lot numbers, and supplier names. Records matter because recalls sometimes trace back to old batches, or an odd impurity. Tracking everything creates a path for quick problem-solving if regulators come knocking.
Finding ways to do better always helps. Installing humidity sensors lets staff spot problems before moisture spreads. Automatic temperature logs catch unauthorized storage—nobody wants a drum left by a radiator. Regular checks by trained staff reinforce habits and highlight weak spots.
Safe storage of Yellow Iron Oxide in pharma settings is about more than tidy shelves. Good habits, the right equipment, separation from reactive substances, and smart record-keeping combine to protect both the pigment and patients down the line.
Manufacturers and labs often ask if yellow iron oxide pharma grade lines up with BP, EP, and USP standards. This pigment gets plenty of use in tablets and capsules thanks to its reliable color stability. The British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) all keep a close eye on how raw materials are made and used. Each one outlines clear specs for heavy metal content, purity, identification, and microbial load.
I’ve worked in a regulated pharmaceutical setting where any coloring agent coming through the door had to match these monographs exactly. Nothing went into a product unless every batch had a certificate of analysis that could withstand regulatory scrutiny. For yellow iron oxide, BP, EP, and USP line up on most basics: the pigment should show no signs of contamination, shouldn’t be laced with heavy metals beyond safe thresholds, and has to meet specific limits for arsenic, lead, and mercury. Particle size, shade, and UV absorption tests also come into play.
Over the last ten years, I’ve seen regulators zero in on traceability more than ever. When a supplier claims their yellow iron oxide is BP/EP/USP grade, that claim means nothing without batch records, lot traceability, and a serious compliance track record. A few years ago, a global generics manufacturer I worked with landed in a recall mess because pigment lots showed trace lead contamination. They followed up with intense supplier audits.
It matters that yellow iron oxide used in pharmaceuticals comes from manufacturers with current Good Manufacturing Practice (cGMP) certification. Labs need to hold on to all batch verification records. Audits by the FDA or EMA can trigger recalls even for low-level non-compliance, and consequences for ignoring standards go far beyond stopping production — reputation and trust can evaporate.
The most effective suppliers run full validation on every lot. They finish the same tests mentioned in BP/EP/USP — checking identity, pH, loss on drying, soluble impurities, and residual solvents. All data needs regular review. Often, companies use third-party testing labs for cross-verification.
It’s not enough to point to a compliance claim on a product label. Suppliers must show test results for every lot sold. Any reputable pharma manufacturing plant sends incoming lots for independent testing anyway. This means companies get an extra layer of assurance without blindly trusting a single provider or third-party reseller.
Some organizations push for even stricter standards than those in the pharmacopoeias because the bar keeps moving. The European Directorate for the Quality of Medicines (EDQM) started issuing tighter monograph updates a few years ago. Suppliers who barely scrape by on the old minimums find themselves spending to update their processes.
In-house training sharpens awareness too. Teams who know why each spec matters, rather than just ticking boxes, tend to spot issues early. Digital tracking and rapid testing equipment help mop up human error. As a result, customers see fewer recalls linked to ingredient mishaps.
Solid partnerships between buyers and pigment producers work best. Buyers get audits and transparency so they’re not left guessing, and suppliers can show real commitment by staying on top of evolving regulations. Keeping open lines to technical support teams at pigment producers can also prevent hiccups — I’ve seen a quick call stop a rollout after a new color shade drifted just outside spec.
Anyone involved in pharma production takes a risk without certainty about their yellow iron oxide’s compliance with BP, EP, and USP. If documentation lags, or specs start to slip, those risks turn into real business pain. It pays to stay curious, keep testing, and demand explanation whenever a specification changes.
| Names | |
| Preferred IUPAC name | Iron(III) oxide |
| Other names |
Yellow Ferric Oxide Ferric Oxide Yellow Iron(III) Oxide Hydrate Hydrated Ferric Oxide Iron Oxide Hydrate CI Pigment Yellow 42 |
| Pronunciation | /ˈjɛl.oʊ ˈaɪərn ɑkˈsaɪd ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ɡreɪd/ |
| Identifiers | |
| CAS Number | 51274-00-1 |
| Beilstein Reference | 13601-19-9 |
| ChEBI | CHEBI:51848 |
| ChEMBL | CHEMBL1201604 |
| ChemSpider | 120038 |
| DrugBank | DB11050 |
| ECHA InfoCard | ECHA InfoCard: 100.030.300 |
| EC Number | 231-409-2 |
| Gmelin Reference | 38120 |
| KEGG | C07213 |
| MeSH | D018473 |
| PubChem CID | 518696 |
| RTECS number | WB4925000 |
| UNII | FJ3Q8TEM47 |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | CompTox Dashboard (EPA)": "DTXSID4035050 |
| Properties | |
| Chemical formula | FeO(OH) |
| Molar mass | 87.85 g/mol |
| Appearance | Appearance: Yellow colored fine powder |
| Odor | Odorless |
| Density | 0.40 to 0.80 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 2.18 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 8.0 – 9.0 |
| Basicity (pKb) | 7.58 |
| Magnetic susceptibility (χ) | 38.5 x 10⁻⁶ (cgs units) |
| Dipole moment | 3.37 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 87.4 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -824.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -824 kJ/mol |
| Pharmacology | |
| ATC code | V07BB |
| Hazards | |
| Main hazards | May cause irritation to eyes, skin, and respiratory tract |
| GHS labelling | GHS07, GHS08, Warning, H315, H319, H335, P261, P305+P351+P338 |
| Pictograms | GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Precautionary statements | Precautionary statements: P261, P264, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P312, P332+P313, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 2-0-0 |
| Autoignition temperature | >1400°C |
| Lethal dose or concentration | LD50 (Oral, Rat): >10,000 mg/kg |
| LD50 (median dose) | > 10,000 mg/kg (oral, rat) |
| PEL (Permissible) | PEL: 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction) |
| REL (Recommended) | 10–100 mg |
| Related compounds | |
| Related compounds |
Red Iron Oxide Black Iron Oxide Brown Iron Oxide Magnesium Oxide Zinc Oxide |
Chengguan District, Lanzhou, Gansu, China
